Episode

Intel & Memory Stocks Surge… And Protagonist CEO On Drug Approval 5/5/26

Podcast: CNBC's "Fast Money"
Published: May 5, 2026
Duration seconds: 2608
Processing state: not_requested
Canonical source: https://www.cnbc.com
Audio: https://dts.podtrac.com/redirect.mp3/cnbc.simplecastaudio.com/b7b89f33-e5b5-46a6-9e42-7f843e9567e5/episodes/0e56911a-ea52-462c-838f-41d620be02d1/audio/128/default.mp3?aid=rss_feed&awCollectionId=b7b89f33-e5b5-46a6-9e42-7f843e9567e5&awEpisodeId=0e56911a-ea52-462c-838f-41d620be02d1&feed=szW8tJ16
JSON: /v1/public/podcasts/cnbc-s-fast-money-385199/episodes/intel-memory-stocks-surge-and-protagonist-ceo-on-drug-approval-5-5-26
Markdown: /podcast/cnbc-s-fast-money-385199/intel-memory-stocks-surge-and-protagonist-ceo-on-drug-approval-5-5-26.md

Actions

POST https://stenobird.com/v1/public/podcasts/cnbc-s-fast-money-385199/episodes/intel-memory-stocks-surge-and-protagonist-ceo-on-drug-approval-5-5-26/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/cnbc-s-fast-money-385199/intel-memory-stocks-surge-and-protagonist-ceo-on-drug-approval-5-5-26.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Semi stocks soaring, as Intel and memory names jump double digits. How much more this trade can climb, and how our traders are positioning in the chip rip. Plus, Meta’s copyright complications, Coinbase cuts heads as AI shakes up the workforce, and the CEO of biopharma company Protagonist on its recent drug approval and the stock’s big run up over the past year. Fast Money Disclaimer